<DOC>
	<DOCNO>NCT01219114</DOCNO>
	<brief_summary>The purpose study monitor safety efficacy CUBICIN condition actual use patient diagnose complicated Skin Skin Structure infection ( cSSI ) Staphylococcus aureus bacteria include right-sided endocarditis prescribe CUBICIN physician .</brief_summary>
	<brief_title>Safety Efficacy Study CUBICIN ( Daptomycin ) Under Conditions Actual Use</brief_title>
	<detailed_description />
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Endocarditis</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Diagnosis cSSSI know suspect due grampositive bacteria Diagnosis rightsided endocarditis one positive culture S. aureus within two day prior initiation medication Prescribed daptomycin patient 's attending physician Known allergic serious adverse reaction daptomycin Patients pneumonia Patients baseline CPK value &gt; 1000 U/L 5x ULN</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Daptomycin</keyword>
	<keyword>endocarditis</keyword>
	<keyword>complicate skin skin structure infection</keyword>
</DOC>